Society of Anesthesia and Sleep Medicine (SASM)
9th Annual Meeting • October 17-18, 2019
 

SASM 2019 LATE BREAKING ABSTRACT SUBMISSION

The Society of Anesthesia and Sleep Medicine (SASM) is now accepting late breaking abstracts for poster presentation at the SASM 9th Annual Meeting, held on October 17-18, 2019 at the Hilton Orlando in Orlando, Florida
 
Abstracts will be reviewed and authors will be notified regarding abstract acceptance for poster presentation via email no later than Friday, September 27th. If accepted, abstract presenters are asked to register and pay full meeting registration fees in order to present their abstract poster.
 
Submitted late breaking abstracts will NOT be eligible for any abstract awards.
      ABSTRACT SUBMISSION GUIDELINES    
Submission Deadline: September 23, 2019
  • Any work related to the following criteria will be considered for presentation: the mechanism of anesthetic, sedation, arousal, memory, intra-operative awareness and post-operative recall, airway physiology, respiratory drive, and sleep disorders.

  • Your abstract must be new and not previously submitted for consideration to another meeting or publication. Exception: If your abstract has been presented elsewhere and you would like to submit it to the 2019 SASM Annual Meeting, your previous presentation must be within one year from October 18, 2019 to be considered.

  • It is the authors' responsibility to ensure not to violate the policy of other meetings where their abstract has previously been presented.

  • The abstracts submitted to the 2019 SASM Annual Meeting can be submitted to and presented at the 2019 ASA Annual Meeting.
     ABSTRACT FORMATTING & PRESENTATION    
  • Abstracts should be brief (a maximum of 500 words, written in 11 point Arial font, single spaced) and be submitted in Microsoft Word Document format (.docx or .doc).
  • For more submission guides, CLICK HERE to download a sample PDF of how to format your abstract.
  • Presenting authors are required to pay meeting registration fees to attend the Annual Meeting.
  • Poster boards and thumbtacks will be provided for poster presenters to hang their posters. Your poster should be no larger than 3 ft wide x 4 ft tall.

AUTHOR INFORMATION

MAIN AUTHOR


CO-AUTHOR
Please list ALL co-authors (maximum of 5 authors, including the presenting author) on your abstract in the format listed below. If your abstract doesn't have any co-authors simply state, "No co-authors."
First and Last Name, Degree(s), Organization/Affiliation
i.e. John Doe, MD, University of California, San Francisco


PRESENTING AUTHOR
The presenting author is the author on the paper that will be present at the Annual Meeting and show your abstract.
 
The presenting author MUST disclose their financial relationships via the financial relationship disclosure information below. 
 
The presenting author must also register for the Annual Meeting and pay applicable registration fees.


FUNDING INFORMATION    

FINANCIAL RELATIONSHIP DISCLOSURE

FOR PRESENTING AUTHORS ONLY

Definition of Financial Relationship

Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria for promotional speakers’ bureau, ownership interest (e.g. stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considered relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

Contracted research includes research funding where the institution gets the grant and manages the fund and the person is the principal or named investigator on the grant.

There is no minimum dollar amount for relationships.

 

Definition of Commercial Interest

A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Providers of clinical service directly to patients are not commercial interests – unless the provider of clinical service is owned, or controlled, by a commercial interest. The following are not commercial interests:

  • 501-C Non-profit organizations that do not advocate for commercial interests
  • Government organizations
  • Non-health care related companies
  • Liability insurance providers
  • Health insurance providers
  • Group medical practices
  • For-profit hospitals
  • For-profit rehabilitation centers
  • For-profit nursing homes
  • Blood banks
  • Diagnostic laboratories
After having read the definitions above, in the past 12 months, have you or your spouse/partner had a financial relationship with any commercial interest? *
If you answered NO, and have not had a financial relationship with a commercial organization,
please skip to the next section: Abstract Title and Submission
 
If you answered YES, and have had a financial relationship with a commercial organization,
please continue to the following question.
 
Please fill out a disclosure for ONLY the presenting author on the abstract.
Statement 1: I will not accept payments or reimbursements from a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients) for my role in the planning and delivery of this CME activity. If I am approached by a commercial interest in this regard, I will immediately notify the Society of Anesthesia and Sleep Medicine. *
Statement 2: Continuing medical education consists of educational activities which serve to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public, or the profession. The content of CME is that body of knowledge and skills generally recognized and accepted by the profession as within the basic medical sciences, the discipline of clinical medicine, and the provision of health care to the public. If I am a presenter, my presentation will meet these standards, and if I’m a planner, I will not approve any content that does not meet these standards. If I am a session chair and/or an abstract discussant, any contribution I make to the discussion, will meet these standards. *
Statement 3: Presentations that promote recommendations, treatment, or manners of practicing medicine that are not within the definition of CME or known to have risks or dangers that outweigh the benefits or known to be ineffective in the treatment of patients, are prohibited. Presentations devoted to advocacy of unscientific modalities of diagnosis or therapy are prohibited. If I am a presenter, my presentation will meet these standards, and if I’m a planner, I will not approve any content that does not meet these standards. If I am a session chair and/or an abstract discussant, any contribution I make to the discussion, will meet these standards. *
Statement 4: All recommendations involving clinical medicine in a CME activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection and analysis. If I am a presenter, my presentation will meet these standards, and if I’m a planner, I will not approve any content that does not meet these standards. If I am a session chair and/or an abstract discussant, any contribution I make to the discussion, will meet these standards. *
Statement 5: Presentations must give a balanced view of therapeutic options. Use of generic names will contribute to this impartiality. If the CME educational material or content includes trade names, where available trade names from several companies should be used, not just trade names from a single company. If I am a presenter, my presentation will meet this standard, and if I’m a planner, I will not approve any content that does not meet this standard. If I am a session chair and/or an abstract discussant, any contribution I make to the discussion, will meet this standard. *
Statement 6: Educational materials that are a part of this activity, such as slides, abstracts, and handouts, cannot contain any advertising, trade names, product-group messages, or commercial interest logos. If I am a presenter, my presentation will meet this standard, and if I’m a planner, I will not approve any content that does not meet this standard. If I am a session chair and/or an abstract discussant, any contribution I make to the discussion, will meet this standard.  *
Statement 7: The content or format of a CME activity or its related materials must promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest. If I am a presenter, my presentation will meet this standard, and if I’m a planner, I will not approve any content that does not meet this standard. If I am a session chair and/or an abstract discussant, any contribution I make to the discussion, will meet this standard. *
Statement 8: The content of the CME activity must not be influenced by any commercial interest. If I am a presenter, my presentation will meet this standard, and if I'm a planner, I will not approve any content that does not meet this standard.  *
Statement 9: If I participate in a non-faculty role, such as planner or reviewer, I will recuse myself from planning educational content related to my financial relationships, or alternatively, my educational content decisions will be reviewed by a planner who has no conflict of interest and who has sufficient expertise to plan this activity.  *
Statement 10: If I am an abstract reviewer, I will not score any abstracts of which I am an author or which I know to be from my institution. If I or my spouse/domestic partner has a financial relationship with a company engaged in producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients and whose products or services are the subject of an abstract I am reviewing, I will refrain from scoring that abstract. Additionally, I will base my recommendations for content selection solely on the mean score when I or my spouse/domestic partner have a financial relationship with a company engaged in producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients and whose products or services are the subject of an abstract I am selecting. *
Statement 11: If you are an employee or corporate board member of a commercial interest, we will review your disclosure and decide if further action is, or is not, necessary. We will email you and let you know either way. In the meantime, there is nothing else you need to do. *


Abstract Title and Submission


Society of Anesthesia and Sleep Medicine (SASM)
6737 W Washington St, Ste 4210
Milwaukee, WI 53214
 
P: (414) 389-8608 • F: (414) 276-7704
info@sasmhq.org • www.sasmhq.org